CISATRACURIUM BESILATE LYOPHILIZED POWDER-INJECTION PREPARATION - SHANGHAI PHARMA DONGYING JIANGSU PHARMACEUTICAL CO LTD

Title:

CISATRACURIUM BESILATE LYOPHILIZED POWDER-INJECTION PREPARATION

Document Type and Number:

WIPO Patent Application WO/2018/120920

Kind Code:

A1

Abstract:

Disclosed is a cisatracurium besilate lyophilized powder-injection preparation for intravenous administration, which is made of the following components in parts by weight: 1-5 parts of cisatracurium besilate, 10-40 parts of dimyristoylphosphatidylcholine, 5-15 parts of sodium deoxycholate, 0.15-0.50 parts of an antioxidant, 0.5-1 parts of polyvinylpyrrolidone, and 5-25 parts of a lyophilization support agent.

More Like This:

JP6577649	A preparation having a reduced N-formylpiperidine content and / or an suppressed crushing or shrinkage of a lyophilized cake.
WO/2021/100794	ANTIBODY-CONTAINING PREPARATION
JP4890732	Paclitaxel / Liposomal Composition for Cancer Treatment and Method for Producing It

Inventors:

WANG JIAN (CN)
DU FANG (CN)
WANG XIAOYI (CN)
ZHEN GUOYAN (CN)
MIAO MIN (CN)

Application Number:

PCT/CN2017/101871

Publication Date:

July 05, 2018

Filing Date:

September 15, 2017

Export Citation:

Click for automatic bibliography generation Help

Assignee:

SHANGHAI PHARMA DONGYING JIANGSU PHARMACEUTICAL CO LTD (CN)

International Classes:

A61K9/19; A61K31/4725; A61K47/32; A61P21/02; A61P23/00

Foreign References:

CN106619544A	2017-05-10
CN105919950A	2016-09-07
CN101822669A	2010-09-08

Download PDF:

View/Download PDF PDF Help

Previous Patent: VEHICLE, CONTROL METHOD THEREFOR AND STORAGE MEDIUM

Next Patent: MOBILE TERMINAL